Testing different doses of a common pain reliever to prevent colon cancer

This trial is testing aspirin—a medication most people know as a pain reliever—to see if it might help prevent colon cancer in people who have just been diagnosed. Researchers want to figure out the right dose and understand exactly how aspirin works to protect against cancer. The study will also look at blood and urine markers to track how the medication affects your body at the cellular level.

Aspirin shows promise as a cancer-prevention tool, but doctors don't yet know the best dose to use or whether it truly works in people with newly diagnosed colon cancer. This trial will help answer those questions and gather evidence to guide future treatment recommendations.